Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 13, 2026 23.34M
November 12, 2026 25.95M
November 11, 2026 27.78M
November 10, 2026 28.36M
November 09, 2026 24.05M
November 06, 2026 24.12M
November 05, 2026 20.28M
November 04, 2026 20.66M
November 03, 2026 23.04M
November 02, 2026 23.39M
October 30, 2026 24.10M
October 29, 2026 23.06M
October 28, 2026 24.23M
October 27, 2026 22.67M
October 26, 2026 22.37M
October 23, 2026 24.12M
October 22, 2026 25.19M
October 21, 2026 23.47M
October 20, 2026 22.92M
October 19, 2026 23.13M
October 16, 2026 22.19M
October 15, 2026 21.96M
October 14, 2026 19.57M
October 13, 2026 21.27M
October 12, 2026 21.88M
Date Value
October 09, 2026 23.48M
October 08, 2026 23.67M
October 07, 2026 23.35M
October 06, 2026 21.43M
October 05, 2026 23.42M
October 02, 2026 21.51M
October 01, 2026 22.46M
September 30, 2026 22.01M
September 29, 2026 25.84M
September 28, 2026 26.77M
September 25, 2026 27.20M
September 24, 2026 27.66M
September 23, 2026 29.35M
September 22, 2026 26.78M
September 21, 2026 28.69M
September 18, 2026 28.54M
September 17, 2026 28.54M
September 16, 2026 26.77M
September 15, 2026 26.33M
September 14, 2026 25.66M
September 11, 2026 26.77M
September 10, 2026 26.34M
September 09, 2026 26.33M
September 08, 2026 27.66M
September 04, 2026 27.27M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 487.93M
Amgen, Inc. 292.70B
Anika Therapeutics, Inc. 160.67M
BioCryst Pharmaceuticals, Inc. 2.402B
Imunon, Inc. 6.805M